Sangamo Therapeutics Competitors and Similar CompaniesClear all
Evotec's competitors and similar companies include PhaseBio Pharmaceuticals.
 PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. | ||
Founding Date | Founding Date 1993 | Founding Date 2002 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Hamburg, DE HQ Lyon, FR Toulouse, FR Göttingen, DE Halle (Westfalen), DE Köln, DE Munich, DE see more | Locations Malvern, US HQ |
Employees | Employees 4,766 | Employees 22 |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) N/A |
Financial | ||
Revenue (est.) | Revenue (est.) €788.4m (FY, 2025) | Revenue (est.) $10.8m (FY, 2021) |
Net income | Net income (€103.5m) (FY, 2025) | Net income ($131.1m) (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
PhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View company